Back to Companies
Decoy Therapeutics Inc.
DCOYNasdaqCIK: 0001615219
Decoy Therapeutics Inc. (DCOY) shows 4 recent insider filings from 3 insiders, with all of them on the buy side. With $19.7K in purchases and $17 in sales, the recent tape is heavily weighted toward buying (a net purchase of $19.7K). Rosenblum Mark J (Exec VP Finance, CFO) is the most active by dollar volume, and the single largest transaction was $16.0K by Rosenblum Mark J. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$19.8K
Purchases
$19.7K
Sales
$17
Unique Insiders
3
Recent Insider Trades
4 loaded
| Jul 31 | DCOY Decoy Therapeutics Inc. | Gauthier Patricia G. | Insider | Other | $0 |
| Jan 2 | SLRX Salarius Pharmaceuticals, Inc. | HANISH ARNOLD C | Director | Sell | $17 |
| Nov 20 | SLRX Salarius Pharmaceuticals, Inc. | Rosenblum Mark J | Exec VP Finance, CFO | Buy | $16.0K |
| Nov 24 | SLRX Salarius Pharmaceuticals, Inc. | HANISH ARNOLD C | Director | Buy | $3.7K |
4 filings